ALLMedicine™ Mycobacterial Infections Center
Research & Reviews 15 results
https://doi.org/10.1097/MCP.0000000000000764
Current Opinion in Pulmonary Medicine; Gill LI, Dominic C et. al.
Feb 9th, 2021 - Infections caused by nontuberculous mycobacteria (NTM) are increasing for several reasons, including diagnostic advances, increased awareness and a larger at-risk population. NTM pulmonary disease is surpassing tuberculosis (TB) in some low incide...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364491
Journal of Medical Case Reports; Keragala BSDP, Herath HMMTB et. al.
Jul 16th, 2020 - Leprosy is one of the oldest mycobacterial infections and tuberculosis is the most common mycobacterial infection with a higher degree of infectivity than leprosy. Although both diseases are prevalent in clusters in developing countries, simultane...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527651
The European Respiratory Journal; Ong CWM, Migliori GB et. al.
Jun 26th, 2020 - Major epidemics, including some that qualify as pandemics, such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), HIV, influenza A (H1N1)pdm/09 and most recently COVID-19, affect the lung. Tuberculosis (TB) rema...
https://clinicaltrials.gov/ct2/show/NCT00018044
Apr 19th, 2020 - The nontuberculous mycobacteria (NTM) are ubiquitous environmental organisms foundin soil and water that rarely cause disease in humans. Since exposure to these organisms is universal and disease is rare, it can be concluded that normal host defen...
https://doi.org/10.1016/j.clml.2019.08.008
Clinical Lymphoma, Myeloma & Leukemia; Anand K, Burns EA et. al.
Nov 8th, 2019 - Ruxolitinib is a selective Janus kinase inhibitor (JAKI) 1/2 approved for the treatment of myelofibrosis (MF) and polycythemia vera (PV). These patients may be at risk for developing opportunistic infections. We assessed the number of patients tha...
Drugs 137 results see all →
Clinicaltrials.gov 159 results
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fad1e5a3-59f9-4868-9937-d3b061ab8f00
Feb 21st, 2021 - Clarithromycin is a macrolide antimicrobial indicated for mild to moderate infections caused by designated, susceptible bacteria in the following: •Acute Bacterial Exacerbation of Chronic Bronchitis in Adults (1.1) •Acute Maxillary Sinusitis (1.2)...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9143b79c-4c79-43ac-e053-2995a90ad708
Feb 18th, 2021 - Clarithromycin tablets are a macrolide antimicrobial indicated for mild to moderate infections caused by designated, susceptible bacteria in the following: Acute Bacterial Exacerbation of Chronic Bronchitis in Adults ( 1.1) Acute Maxillary Sinusit...
https://doi.org/10.1097/MCP.0000000000000764
Current Opinion in Pulmonary Medicine; Gill LI, Dominic C et. al.
Feb 9th, 2021 - Infections caused by nontuberculous mycobacteria (NTM) are increasing for several reasons, including diagnostic advances, increased awareness and a larger at-risk population. NTM pulmonary disease is surpassing tuberculosis (TB) in some low incide...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99d2fd6b-39ca-42f9-ad06-30e7fbc22c47
Feb 8th, 2021 - Clarithromycin tablets are a macrolide antimicrobial indicated for mild to moderate infections caused by designated, susceptible bacteria in the following: • Acute Bacterial Exacerbation of Chronic Bronchitis in Adults (1.1) • Acute Maxillar...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ba0d460e-fc4a-58fd-e053-2a95a90a4595
Jan 28th, 2021 - Clarithromycin is a macrolide antimicrobial indicated for mild to moderate infections caused by designated, susceptible bacteria in the following: Acute Bacterial Exacerbation of Chronic Bronchitis in Adults (1.1) Acute Maxillary Sinusitis (1.2) C...
News 1 results
https://www.medscape.com/viewarticle/909753_3
Conclusion The use of biologics is now a standard therapy for IBD used either as monotherapy or in combination with immunomodulators. A review of safety data of currently used biologics show cumulative evidence for anti-TNF as they have been used ...